Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management
Trinity Biotech plc - American Depositary Shares (TRIB)
Last trinity biotech plc - american depositary shares earnings: 10/26 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
trinitybiotech.com/investor-relations
Company Research
Source: Business Wire
Stem-cell innovator poised to advance the commercialization of its cancer treatment, with $30 million of initial new capital and access to substantial additional funds to drive growthExperienced management team joins company, with more than 80 years of cumulative experience expanding access to innovative treatments for the patients who need them most BOSTON--(BUSINESS WIRE)--Gamida Cell (the “Company”), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced new executive leadership following a successful restructuring transaction ("Transaction”) with certain funds managed by Highbridge Capital Management, LLC (collectively, “Highbridge”) on May 24, 2024. As part of the Transaction, Highbridge invested $30 million of new capital into Gamida Cell, and is expected to provide substantial additional capital to support ongoing operations, including the research and development, manufacturing, and commercialization of its cell therapeutics. Following the
Show less
Read more
Impact Snapshot
Event Time:
TRIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRIB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRIB alerts
High impacting Trinity Biotech plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TRIB
News
- Trinity Biotech's Stock Rises After Acquisition of Metabolomics [Yahoo! Finance]Yahoo! Finance
- Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health MarketGlobeNewswire
- Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with BayerGlobeNewswire
- Autoimmune Disease Testing Market to Reach $12.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market ResearchPR Newswire
- Autoimmune Disease Testing Market to Reach $12.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market ResearchPR Newswire
TRIB
Sec Filings
- 9/25/24 - Form 6-K
- 9/23/24 - Form 6-K
- 9/20/24 - Form 424B5
- TRIB's page on the SEC website